Delivery Order SPE2DB22D1103-SPE2DB24FTFT5
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $3,091.82 firm fixed price delivery order from the Defense Logistics Agency (DLA) for 100 units of DEXMETHYLPHENIDATE ER 20 MG CP. The contract has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. Additionally, Amerisourcebergen Drug...
- This federal contract award is for the delivery of DEXMETHYLPHENIDATE ER 15 MG CP 100S, a generic prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,048.31 and has an ultimate completion date of February 21, 2025. This contract is not designated as a set-aside....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563830694 - DEXMETHYLPHENIDATE ER 10 MG CP 100S. The contract has a potential value of $1,937.33 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not associated with any set-aside designation. This delivery order is placed...
- This federal contract award, valued at $2,307.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 25 MG CP 100S, a pharmaceutical product, with a completion date of February 12, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not associated with a set-aside program, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S. The fixed-price delivery order, valued at $1,063.28, has a period of performance through February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,842,180 units of the pharmaceutical product DEXMETHYLPHENIDATE ER 20 MG CP 100S. The contract has a potential value of $2,073.02 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which does not have a set-aside designation. The...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of DEXMETHYLPHENIDATE ER 25 MG CP 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order has a potential value of $4,310.57 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, holds an indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564110591 - DEXMETHYLPHENIDATE ER 10 MG CP 100S. The $1,099.87 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is also the holder of a $999,999,999.00 indefinite delivery contract (IDC) with DLA to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,249,964 dosages of the pharmaceutical product DEXMETHYLPHENIDATE ER 10 MG CP. The firm fixed-price delivery order has a potential value of $2,074.79 and a performance completion date of January 8, 2024. As the prime contractor, Amerisourcebergen Drug Corp has been awarded numerous federal contracts by DLA to supply...
- This federal contract award is for the delivery of DEXMETHYLPHENIDATE ER 20 MG CP 100S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that supplies a wide range of medical products to government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $1,507.26, is a firm fixed-price delivery order with a period of performance...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFT5Delivery Order
This federal contract award is for the delivery of DEXMETHYLPHENIDATE ER 20 MG CP 100S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $2,846.10 and a completion date of February 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/28/24 |